Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
351
Price
$209.10
Total Value
$73.39K
Shares Held After
68,068
% of Holdings
0.5%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
1,619
Price
$208.21
Total Value
$337.09K
Shares Held After
68,419
% of Holdings
2.3%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
3,500
Price
$207.08
Total Value
$724.79K
Shares Held After
70,038
% of Holdings
4.8%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
10,122
Price
$206.37
Total Value
$2.09M
Shares Held After
73,538
% of Holdings
12.1%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Feb 13, 2026
Sale
Shares
10,573
Price
$205.21
Total Value
$2.17M
Shares Held After
83,660
% of Holdings
11.2%
Feb 13, 2026
Sale
Shares
2,000
Price
$102.09
Total Value
$204.18K
Shares Held After
0
% of Holdings
100.0%

ANI PHARMACEUTICALS INC (ANIP)

Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Feb 13, 2026
Sale
Shares
500
Price
$76.80
Total Value
$38.40K
Shares Held After
69,329
% of Holdings
0.7%
Feb 13, 2026
Sale
Shares
10,000
Price
$5.81
Total Value
$58.14K
Shares Held After
204,657
% of Holdings
4.7%

Twist Bioscience Corp (TWST)

Finn Patrick John — President and COO
Feb 13, 2026
Sale
Shares
1,750
Price
$50.04
Total Value
$87.57K
Shares Held After
306,250
% of Holdings
0.6%

Hyperfine, Inc. (HYPR)

TEISSEYRE THOMAS — Chief Operating Officer
Feb 13, 2026
Sale
Shares
821
Price
$1.11
Total Value
$912.54
Shares Held After
378,836
% of Holdings
0.2%
Feb 13, 2026
Purchase
Shares
16,100
Price
$8.96
Total Value
$144.27K
Shares Held After
258,792
% of Holdings
6.2%
Feb 13, 2026
Purchase
Shares
11,092
Price
$9.14
Total Value
$101.41K
Shares Held After
242,692
% of Holdings
4.6%
Feb 13, 2026
Sale
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Feb 13, 2026
Sale
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Feb 13, 2026
Sale
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Feb 13, 2026
Sale
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%

Roivant Sciences Ltd. (ROIV)

QVT Financial LP — Director by Deputization
Feb 13, 2026
Sale
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%

Roivant Sciences Ltd. (ROIV)

QVT Financial LP — Director by Deputization
Feb 13, 2026
Sale
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom — Chief Medical Officer
Feb 13, 2026
Sale
Shares
6,348
Price
$27.58
Total Value
$175.10K
Shares Held After
44,089
% of Holdings
12.6%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom — Chief Medical Officer
Feb 13, 2026
Sale
Shares
4,166
Price
$27.33
Total Value
$113.86K
Shares Held After
50,437
% of Holdings
7.6%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom — Chief Medical Officer
Feb 13, 2026
Sale
Shares
3,541
Price
$27.33
Total Value
$96.78K
Shares Held After
50,437
% of Holdings
6.6%

IONIS PHARMACEUTICALS INC (IONS)

Swayze Eric — EVP Research
Feb 13, 2026
Sale
Shares
6,207
Price
$82.07
Total Value
$509.40K
Shares Held After
32,105
% of Holdings
16.2%

IONIS PHARMACEUTICALS INC (IONS)

Swayze Eric — EVP Research
Feb 13, 2026
Sale
Shares
9,435
Price
$81.56
Total Value
$769.51K
Shares Held After
38,312
% of Holdings
19.8%
Feb 13, 2026
Purchase
Shares
4,160
Price
$26.36
Total Value
$109.66K
Shares Held After
19,860
% of Holdings
20.9%
Feb 13, 2026
Purchase
Shares
10,000
Price
$23.96
Total Value
$239.59K
Shares Held After
27,775
% of Holdings
36.0%

IRADIMED CORP (IRMD)

ALLEN MONTY K — Director
Feb 13, 2026
Sale
Shares
1,000
Price
$100.26
Total Value
$100.26K
Shares Held After
21,000
% of Holdings
4.5%

QuidelOrtho Corp (QDEL)

Busky Joseph M. — Chief Financial Officer
Feb 13, 2026
Purchase
Shares
3,370
Price
$23.66
Total Value
$79.74K
Shares Held After
10,290
% of Holdings
32.8%

QuidelOrtho Corp (QDEL)

Blaser Brian J. — President and CEO
Feb 13, 2026
Purchase
Shares
10,540
Price
$23.59
Total Value
$248.66K
Shares Held After
40,073
% of Holdings
26.3%

WEED, INC. (BUDZ)

BREEN NICOLE M — Director
Feb 12, 2026
Sale
Shares
35,000
Price
$0.03
Total Value
$1.14K
Shares Held After
30,210,988
% of Holdings
0.1%

TALPHERA, INC. (TLPH)

ASADORIAN RAFFI — Chief Financial Officer
Feb 12, 2026
Purchase
Shares
45,000
Price
$0.81
Total Value
$36.55K
Shares Held After
91,256
% of Holdings
49.3%

TALPHERA, INC. (TLPH)

Aslam Shakil — Chief Medical Officer
Feb 12, 2026
Purchase
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
83,178
% of Holdings
42.1%
Feb 12, 2026
Purchase
Shares
105,364
Price
$0.81
Total Value
$85.59K
Shares Held After
586,954
% of Holdings
18.0%

TALPHERA, INC. (TLPH)

Dasu Badri N — Chief Engineering Officer
Feb 12, 2026
Purchase
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
76,230
% of Holdings
45.9%
Feb 12, 2026
Sale
Shares
300,000
Price
$0.02
Total Value
$5.58K
Shares Held After
25,393
% of Holdings
92.2%

Neuronetics, Inc. (STIM)

MACAN WILLIAM ANDREW — EVP, CLO and CS
Feb 12, 2026
Sale
Shares
14,120
Price
$1.65
Total Value
$23.30K
Shares Held After
673,561
% of Holdings
2.1%
Feb 12, 2026
Sale
Shares
33,847
Price
$1.65
Total Value
$55.85K
Shares Held After
1,533,165
% of Holdings
2.2%

OCULAR THERAPEUTIX, INC (OCUL)

Nayak Sanjay — Chief Strategy Officer
Feb 12, 2026
Sale
Shares
10,348
Price
$9.04
Total Value
$93.55K
Shares Held After
332,412
% of Holdings
3.0%
Feb 12, 2026
Sale
Shares
124,882
Price
$9.04
Total Value
$1.13M
Shares Held After
3,033,078
% of Holdings
4.0%

OCULAR THERAPEUTIX, INC (OCUL)

Notman Donald — Chief Operating Officer
Feb 12, 2026
Sale
Shares
11,446
Price
$9.04
Total Value
$103.47K
Shares Held After
366,356
% of Holdings
3.0%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick — Chief Commercial Officer
Feb 12, 2026
Sale
Shares
20,000
Price
$23.37
Total Value
$467.40K
Shares Held After
43,298
% of Holdings
31.6%

Heartflow, Inc. (HTFL)

Rogers Campbell — Chief Medical Officer
Feb 12, 2026
Sale
Shares
65,153
Price
$24.49
Total Value
$1.60M
Shares Held After
76,034
% of Holdings
46.1%

BIOGEN INC. (BIIB)

Murphy Nicole — Head of Pharm Ops and Tech
Feb 12, 2026
Purchase
Shares
3
Price
$195.03
Total Value
$585.11
Shares Held After
19,611
% of Holdings
0.0%

OCULAR THERAPEUTIX, INC (OCUL)

Waheed Nadia — Chief Medical Officer
Feb 12, 2026
Sale
Shares
7,863
Price
$9.04
Total Value
$71.08K
Shares Held After
318,417
% of Holdings
2.4%

JOINT Corp (JYNT)

JOBSON CHARLES E — 10% Owner
Feb 12, 2026
Purchase
Shares
15,397
Price
$8.50
Total Value
$130.87K
Shares Held After
1,645,294
% of Holdings
0.9%

GLOBUS MEDICAL INC (GMED)

Huller Kelly — EVP, GC, Corporate Secretary
Feb 12, 2026
Sale
Shares
10,000
Price
$87.67
Total Value
$876.70K
Shares Held After
0
% of Holdings
100.0%

DEXCOM INC (DXCM)

Heller Bridgette P — Director
Feb 12, 2026
Sale
Shares
1,012
Price
$68.01
Total Value
$68.83K
Shares Held After
26,019
% of Holdings
3.7%
Feb 12, 2026
Purchase
Shares
62,500
Price
$0.40
Total Value
$25.00K
Shares Held After
297,090
% of Holdings
21.0%
Feb 12, 2026
Purchase
Shares
1,000,000
Price
$0.40
Total Value
$400.00K
Shares Held After
1,050,000
% of Holdings
95.2%
Feb 12, 2026
Purchase
Shares
96,150
Price
$0.40
Total Value
$38.46K
Shares Held After
174,037
% of Holdings
55.2%
Feb 12, 2026
Purchase
Shares
212,500
Price
$0.40
Total Value
$85.00K
Shares Held After
212,500
% of Holdings
100.0%
Version: v26.3.33